Skip to main content

Table 1 Clinical and demographic features of patients

From: Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes

 

No. of Non-smokers Patients

Mean ± SD

No. of Patients with COPD

Mean ± SD

Age, y

11

64 ± 8

 

11

66 ± 9

Sex, no. male/female

5/6

  

8/3

 

Smoking status

 Never smoked

11

  

0

 

 Former/Current

0/0

  

4/7

 

Pack-years

11

0

 

11

52.2 ± 32

GOLD 0/1/2/3/4

11/0/0/0/0

  

0/3/8/0/0

 

FEV1/FVC, %

11

77.2 ± 5

 

11

60.4 ± 9*

FEV1, % predicted value

11

107.2 ± 10

 

11

73.2 ± 15*

VC, L

11

3.5 ± 1

 

11

3.6 ± 1

  1. COPD chronic obstructive pulmonary disease, GOLD global initiative for chronic obstructive lung disease
  2. *p < 0.001 compared with control